4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-007282
Options or other derivatives
- Chief Financial Officer acquired 539,698 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2025-03-04 | Grant or award · Employee Stock Option (right to buy) | +330,882 | 330,882 | D | ||
| McCombe William D. Chief Financial Officer | 2025-03-04 | Grant or award · Restricted Stock Units | +208,816 | 208,816 | D | ||
Loading xslF345X05/form4-03062025_100326.xml…